Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drospirenone/Estetrol for Endometrial Preparation
NCT06316180Phase 4Completed
- Sponsor
- University of Palermo
- Start
- Jan 2023
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of estetrol and drospirenone in endometrial polyp (2 arms), sponsored by University of Palermo. Primary endpoint: Quality of endometrial preparation. Started Jan 2023; status: completed.
02
Drugs
estetroldrospirenone
03
Conditions
endometrial polyp
Beyond the preview
Go deeper on NCT06316180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06316180.